Ratings by Janney (Esther Hong)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/18/2020 | Agile Therapeutics | AGRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2020 | Concert Pharmaceuticals | CNCE | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2019 | Baudax Bio Inc. | BXRX | New Coverage | Buy (N/A) |
0.00 (0.19) |
0% | Details | |
| 9/9/2019 | Spero Therapeutics | SPRO | New Coverage | Buy (N/A) |
9.98 (1.22) |
-87.78% | Details | |
| 9/4/2019 | Concert Pharmaceuticals | CNCE | Maintain | Buy (Buy) |
|
Details | ||
| 6/13/2019 | Concert Pharmaceuticals | CNCE | Upgrade | Buy (Neutral) |
10.09 (8.37) |
-17.05% | Details | |
| 5/29/2019 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2019 | Collegium Pharmaceutical | COLL | New Coverage | Buy (N/A) |
16.40 (27.11) |
65.3% | Details | |
| 4/12/2019 | Agile Therapeutics | AGRX | New Coverage | Buy (N/A) |
1.48 (1.51) |
2.03% | Details | |
| 4/12/2019 | PLx Pharma | PLXP | New Coverage | Buy (N/A) |
5.20 (0.09) |
-98.27% | Details | |
| 3/15/2019 | BioDelivery Sciences International | BDSI | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2019 | Recro Pharma | REPH | New Coverage | Buy (N/A) |
7.69 (2.09) |
-72.82% | Details | |
| 1/31/2019 | BioDelivery Sciences International | BDSI | New Coverage | Buy (N/A) |
4.46 (5.59) |
25.34% | Details | |
| 12/20/2018 | Cara Therapeutics | CARA | New Coverage | Buy (N/A) |
13.80 (5.32) |
-61.45% | Details | |
| 11/6/2018 | Clearside Biomedical | CLSD | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2018 | Concert Pharmaceuticals | CNCE | New Coverage | Neutral (N/A) |
14.10 (10.09) |
-28.44% | Details | |
| 9/13/2018 | Aldeyra Therapeutics | ALDX | New Coverage | Buy (N/A) |
8.25 (1.52) |
-81.58% | Details |
